Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab. - Matsumoto T; Ikoma T; Yamamura S; Miura K; Tsuduki T; Watanabe T; Nagai H; Takatani M; Yasui H (Scientific reports, 2023)